368 related articles for article (PubMed ID: 19635566)
1. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
Allday MJ
Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
Bornkamm GW
Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
[TBL] [Abstract][Full Text] [Related]
3. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract][Full Text] [Related]
4. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
5. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.
Bieging KT; Swanson-Mungerson M; Amick AC; Longnecker R
Cell Cycle; 2010 Mar; 9(5):901-8. PubMed ID: 20160479
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Kelly G; Bell A; Rickinson A
Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
9. Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
Ikeda M; Hayes CK; Schaller SJ; Longnecker R
Blood Adv; 2022 Jul; 6(14):4283-4296. PubMed ID: 35605249
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
Cen O; Longnecker R
Mol Cancer Ther; 2011 Apr; 10(4):679-86. PubMed ID: 21282357
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch.
Pajic A; Polack A; Staege MS; Spitkovsky D; Baier B; Bornkamm GW; Laux G
J Gen Virol; 2001 Dec; 82(Pt 12):3051-3055. PubMed ID: 11714983
[TBL] [Abstract][Full Text] [Related]
12. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
Rowe M; Kelly GL; Bell AI; Rickinson AB
Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
14. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma.
Mawson AR; Majumdar S
Int J Cancer; 2017 Nov; 141(9):1849-1855. PubMed ID: 28707393
[TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
Leao M; Anderton E; Wade M; Meekings K; Allday MJ
J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
[TBL] [Abstract][Full Text] [Related]
16. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
17. Epstein barr virus IgG and EBER-1 in Burkitt's lymphoma children at a referral hospital in western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge CN
Pan Afr Med J; 2019; 34():206. PubMed ID: 32180880
[TBL] [Abstract][Full Text] [Related]
18. Two Pathways of p27
Sora RP; Ikeda M; Longnecker R
mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
Bornkamm GW
Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
[TBL] [Abstract][Full Text] [Related]
20. Burkitt lymphoma--a stalking horse for cancer research?
Klein G
Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
